CORT

CORCEPT THERAPEUTICS INC

Healthcare | Mid Cap

-$0.29

EPS Forecast

$175.7

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.29

Revenue Forecast:

$175.7

EPS Surprise Forecast:

-$0.007

Revenue Surprise Forecast:

-$3

Post-release price volatility - Very high

Post-release Overnight Move:

±12.7%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

51%

Probability of beating revenue consensus:

41%

Probability of beating both EPS & revs consensus:

28%

Probability of missing both EPS & revs consensus:

36%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-5

Beta (β)

Forward Looking Beta (β):

1.66

Earnings volatility

EPS standard deviation:

$0.36

Revenue standard deviation:

$22

As % of share price:

1.06% VERY HIGH

As % of market cap:

0.60% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.19

Revenue 95th %ile:

$204

EPS 75th %ile:

-$0.16

Revenue 75th %ile:

$183

EPS 25th %ile:

-$0.39

Revenue 25th %ile:

$169

EPS 5th %ile:

-$0.69

Revenue 5th %ile:

$152

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

43% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

76% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$22

Bid-ask per Share:

$0.075